Related Experiment Videos
Vaginal misoprostol for early second-trimester abortion
J L Carbonell1, L Valera, A Velazco
1Hospital Docente Gineco-Obstétrico Eusebio Hernández (Maternidad Obrera), Ciudad de la Habana, Cuba.
Summary
Vaginal misoprostol effectively terminated early second-trimester pregnancies in 80% of women, avoiding the need for surgical curettage. This method demonstrated a safe and viable alternative for pregnancy termination.
Area of Science:
- Reproductive Medicine
- Pharmacology
Background:
- Early second-trimester abortions (13-15 weeks' gestation) often require invasive procedures.
- Exploring less invasive medical abortion methods is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the efficacy and safety of vaginal misoprostol for early second-trimester abortions.
- To assess the necessity of postexpulsion curettage when using misoprostol.
Main Methods:
- 151 women (85-105 days gestation) received 800 mcg vaginal misoprostol every 24 hours for up to three doses.
- Systematic postexpulsion curettage was not performed.
- Outcomes included abortion success, side-effects, expulsion time, and bleeding duration.
Main Results:
- Complete abortion was achieved in 80% (121/151) of subjects.
- Hemoglobin decrease was statistically significant but clinically insignificant.
- Vaginal bleeding averaged 12 days, with no significant differences based on patient characteristics.
Conclusions:
- Vaginal misoprostol is an effective and safe alternative for early second-trimester pregnancy termination.
- The procedure avoids the need for routine postabortion curettage.
- This medical approach offers a viable option for managing gestations up to 15 weeks.